CXCR4 upregulation is an indicator of sensitivity to B-cell receptor/PI3K blockade and a potential resistance mechanism in B-cell receptor-dependent diffuse large B-cell lymphomas.
Haematologica
; 105(5): 1361-1368, 2020 05.
Article
in En
| MEDLINE
| ID: mdl-31471373
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, Large B-Cell, Diffuse
/
Phosphatidylinositol 3-Kinases
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Haematologica
Year:
2020
Type:
Article
Affiliation country:
United States